BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069-2077. [PMID: 15082726 DOI: 10.1200/jco.2004.08.026] [Cited by in Crossref: 617] [Cited by in F6Publishing: 235] [Article Influence: 36.3] [Reference Citation Analysis]
Number Citing Articles
1 Schimanski CC, Schlaegel F, Jordan M, Moehler M, Sgourakis G, Drescher DG, Galle PR, Lang H, Gockel I. VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. World J Surg 2011;35:1010-6. [PMID: 21387130 DOI: 10.1007/s00268-011-1041-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
2 Hyung WJ, Woo Y, Noh SH. Robotic surgery for gastric cancer: a technical review. J Robot Surg 2011;5:241-9. [PMID: 27628113 DOI: 10.1007/s11701-011-0263-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer. 2019;22:853-863. [PMID: 30483985 DOI: 10.1007/s10120-018-0902-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
4 Suda K, Nakauchi M, Inaba K, Ishida Y, Uyama I. Minimally invasive surgery for upper gastrointestinal cancer: Our experience and review of the literature. World J Gastroenterol. 2016;22:4626-4637. [PMID: 27217695 DOI: 10.3748/wjg.v22.i19.4626] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
5 van der Werf LR, Eshuis WJ, Draaisma WA, van Etten B, Gisbertz SS, van der Harst E, Liem MSL, Lemmens VEPP, Wijnhoven BPL, Besselink MG, van Berge Henegouwen MI; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group. Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer. J Gastrointest Surg 2019;23:2327-37. [PMID: 30820797 DOI: 10.1007/s11605-019-04133-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata T, Kim BS, Matsuki N, Sawa T, Noh SH; East Asia Surgical Oncology Group. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13:132-137. [PMID: 18463957 DOI: 10.1007/s10147-007-0727-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 4.5] [Reference Citation Analysis]
7 Koeda K, Nishizuka S, Wakabayashi G. Minimally invasive surgery for gastric cancer: the future standard of care. World J Surg. 2011;35:1469-1477. [PMID: 21476116 DOI: 10.1007/s00268-011-1051-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
8 Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, Webb CC, Walker M, Toomey MA, Schrump D, Pandalai P, Stojadinovic A, Avital I. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 2014;110:275-84. [PMID: 25042700 DOI: 10.1002/jso.23633] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 11.1] [Reference Citation Analysis]
9 Scatizzi M, Kröning KC, Lenzi E, Moraldi L, Cantafio S, Feroci F. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a case-control study. Updates Surg. 2011;63:17-23. [PMID: 21286896 DOI: 10.1007/s13304-011-0043-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
10 Pang X, Wei W, Leng W, Chen Q, Xia H, Chen L, Li R. Radiotherapy for gastric cancer: a systematic review and meta-analysis. Tumour Biol. 2014;35:387-396. [PMID: 23929390 DOI: 10.1007/s13277-013-1054-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xiong JJ, Nunes QM, Huang W, Tan CL, Ke NW, Xie SM, Ran X, Zhang H, Chen YH, Liu XB. Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19:8114-8132. [PMID: 24307808 DOI: 10.3748/wjg.v19.i44.8114] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
12 Zhu Z, Li L, Xu J, Ye W, Zeng J, Chen B, Huang Z. Laparoscopic versus open approach in gastrectomy for advanced gastric cancer: a systematic review. World J Surg Oncol 2020;18:126. [PMID: 32534587 DOI: 10.1186/s12957-020-01888-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ott K, Lordick F. [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint]. Chirurg 2009;80:1028-34. [PMID: 19756431 DOI: 10.1007/s00104-009-1736-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol. 2010;16:5621-5628. [PMID: 21105197 DOI: 10.3748/wjg.v16.i44.5621] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
15 Wu XS, Wu WG, Li ML, Yang JH, Ding QC, Zhang L, Mu JS, Gu J, Dong P, Lu JH, Liu YB. Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 2013;19:4596-606. [PMID: 23901238 DOI: 10.3748/wjg.v19.i27.4596] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
16 Chen T, Yan D, Zheng Z, Yang J, Dong XDE. Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA? World J Surg Oncol. 2017;15:135. [PMID: 28716043 DOI: 10.1186/s12957-017-1204-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 2012;7:e38681. [PMID: 22723875 DOI: 10.1371/journal.pone.0038681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
18 Suttie SA, Li AG, Quinn M, Park KG. The impact of operative approach on outcome of surgery for gastro-oesophageal tumours. World J Surg Oncol 2007;5:95. [PMID: 17708773 DOI: 10.1186/1477-7819-5-95] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Roy MK, Sadhu S, Dubey SK. Advances in the management of gastric cancer. Indian J Surg. 2009;71:342-349. [PMID: 23133189 DOI: 10.1007/s12262-009-0092-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Memon MA, Butler N, Memon B. The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma. World J Gastrointest Oncol 2010;2:65-7. [PMID: 21160923 DOI: 10.4251/wjgo.v2.i2.65] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
21 Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One. 2014;9:e88753. [PMID: 24558421 DOI: 10.1371/journal.pone.0088753] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
22 Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
23 Blank S, Bläker H, Schaible A, Lordick F, Grenacher L, Buechler M, Ott K. Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbecks Arch Surg 2012;397:45-55. [PMID: 21598045 DOI: 10.1007/s00423-011-0805-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
24 Mocan L. Surgical Management of Gastric Cancer: A Systematic Review. J Clin Med 2021;10:2557. [PMID: 34207898 DOI: 10.3390/jcm10122557] [Reference Citation Analysis]
25 Goto H, Tokunaga M, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer. 2013;16:590-595. [PMID: 23179369 DOI: 10.1007/s10120-012-0214-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
26 Nakauchi M, Suda K, Kadoya S, Inaba K, Ishida Y, Uyama I. Technical aspects and short- and long-term outcomes of totally laparoscopic total gastrectomy for advanced gastric cancer: a single-institution retrospective study. Surg Endosc. 2016;30:4632-4639. [PMID: 26703126 DOI: 10.1007/s00464-015-4726-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
27 Yu C, Xue P, Zhang L, Pan R, Cai Z, He Z, Sun J, Zheng M. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer. World J Surg Oncol 2018;16:174. [PMID: 30134903 DOI: 10.1186/s12957-018-1475-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
28 Brenkman HJF, Goense L, Brosens LA, Haj Mohammad N, Vleggaar FP, Ruurda JP, van Hillegersberg R. A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study. Ann Surg Oncol 2017;24:2213-23. [PMID: 28247154 DOI: 10.1245/s10434-017-5815-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
29 Snyder RA, Castaldo ET, Bailey CE, Phillips SE, Chakravarthy AB, Merchant NB. Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Int J Surg Oncol. 2012;2012:307670. [PMID: 22778937 DOI: 10.1155/2012/307670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Dikken JL, van de Velde CJ, Gönen M, Verheij M, Brennan MF, Coit DG. The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol. 2012;19:2443-2451. [PMID: 22618718 DOI: 10.1245/s10434-012-2403-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
31 Chuang J, Gong J, Klempner SJ, Woo Y, Chao J. Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification. J Gastrointest Oncol 2018;9:560-72. [PMID: 29998022 DOI: 10.21037/jgo.2018.03.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
32 Liu Z, Feng F, Guo M, Liu S, Zheng G, Xu G, Lian X, Fan D, Zhang H. Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore). 2017;96:e6003. [PMID: 28151896 DOI: 10.1097/md.0000000000006003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Borggreve AS, Goense L, Brenkman HJF, Mook S, Meijer GJ, Wessels FJ, Verheij M, Jansen EPM, van Hillegersberg R, van Rossum PSN, Ruurda JP. Imaging strategies in the management of gastric cancer: current role and future potential of MRI. Br J Radiol 2019;92:20181044. [PMID: 30789792 DOI: 10.1259/bjr.20181044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
34 Zhou ML, Kang M, Li GC, Guo XM, Zhang Z. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis. World J Surg Oncol 2016;14:209. [PMID: 27502921 DOI: 10.1186/s12957-016-0957-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
35 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M, Cats A. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2407-11-329] [Cited by in Crossref: 136] [Cited by in F6Publishing: 123] [Article Influence: 13.6] [Reference Citation Analysis]
36 Oh SC. Update of adjuvant chemotherapy for resected gastric cancer. J Gastric Cancer. 2012;12:3-6. [PMID: 22500257 DOI: 10.5230/jgc.2012.12.1.3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
37 Yang K, Choi YY, Zhang WH, Chen XZ, Song MK, Lee J, Zhang B, Chen ZX, Kim HI, Chen JP. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget. 2016;7:44660-44675. [PMID: 27191995 DOI: 10.18632/oncotarget.9378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
38 Mueller JL, Kim DH, Stapleton S, Cauley CE, Chang DC, Park CH, Song KY, Mullen JT. Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer. Gastric Cancer 2019;22:446-55. [PMID: 30167904 DOI: 10.1007/s10120-018-0869-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
39 Lu S, Yan M, Li C, Yan C, Zhu Z, Lu W. Machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy. Chin J Cancer Res 2019;31:797-805. [PMID: 31814683 DOI: 10.21147/j.issn.1000-9604.2019.05.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Brind'Amour A, Gagné JP, Hogue JC, Poirier É. Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting. Can J Surg 2021;64:E119-26. [PMID: 33651574 DOI: 10.1503/cjs.019919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 2008;14:3773-80. [PMID: 18609699 DOI: 10.3748/wjg.14.3773] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
42 Guan G, Jiang W, Chen Z, Liu X, Lu H, Zhang X. Early results of a modified splenic hilar lymphadenectomy in laparoscopy-assisted total gastrectomy for gastric cancer with stage cT1-2: a case–control study. Surg Endosc 2013;27:1923-31. [DOI: 10.1007/s00464-012-2688-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
43 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
44 Huang CM, Lin BJ, Lu HS, Zhang XF, Li P, Xie JW. Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus. World J Gastroenterol 2008;14:4216-21. [PMID: 18636669 DOI: 10.3748/wjg.14.4216] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
45 Chen FF, Huang DD, Lu JX, Zhou CJ, Zhuang CL, Wang SL, Shen X, Yu Z, Chen XL. Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes. J Gastrointest Surg 2016;20:521-30. [PMID: 26691150 DOI: 10.1007/s11605-015-3059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Chang JS, Choi Y, Shin J, Kim KH, Keum KC, Kim HS, Koom WS, Park EC. Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea. Cancer Res Treat 2018;50:118-28. [PMID: 28279066 DOI: 10.4143/crt.2016.575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
47 Oh SC. Update of adjuvant chemotherapy for resected gastric cancer. J Gastric Cancer. 2012;12:3-6. [PMID: 22500257 DOI: 10.5230/jgc.2012.12.1.] [Reference Citation Analysis]
48 Baré M, Cabrol J, Real J, Navarro G, Campo R, Pericay C, Sarría A. In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions. BMC Public Health 2009;9:312. [PMID: 19709446 DOI: 10.1186/1471-2458-9-312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
49 Oh HS, Eom DW, Kang GH, Ahn YC, Lee SJ, Kim JH, Jang HJ, Kim EJ, Oh KH, Ahn HJ. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection. Gastric Cancer. 2014;17:402-411. [PMID: 23955257 DOI: 10.1007/s10120-013-0288-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
50 Park JH, Lee HJ, Oh SY, Park SH, Berlth F, Son YG, Kim TH, Huh YJ, Yang JY, Lee KG, Suh YS, Kong SH, Yang HK. Prediction of Postoperative Mortality in Patients with Organ Failure After Gastric Cancer Surgery. World J Surg 2020;44:1569-77. [PMID: 31993720 DOI: 10.1007/s00268-020-05382-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Shen DF, Chen DW, Quan ZW, Dong P, Wang XF, Xu HZ, Zhao ML, Chen L. Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma. World J Gastroenterol 2008;14:936-8. [PMID: 18240353 DOI: 10.3748/wjg.14.936] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
52 Schuhmacher C, Novotny A, Ott K, Feith M, Siewert JR. [Lymphadenectomy with tumors of the upper gastrointestinal tract]. Chirurg 2007;78:203-6, 208-12, 214-6. [PMID: 17333037 DOI: 10.1007/s00104-007-1307-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
53 de Pascale S, Belotti D, Celotti A, Minerva EM, Quagliuolo V, Rosati R, Romario UF. Prognostic factors for short-term and long-term outcomes of gastric cancer surgery for elderly patients: 10 years of experience at a single tertiary care center. Updates Surg 2018;70:265-71. [PMID: 29961192 DOI: 10.1007/s13304-018-0548-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative. J Surg Oncol 2016;113:750-5. [PMID: 26996496 DOI: 10.1002/jso.24227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
55 Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Wang JB. Impact of the number of dissected lymph nodes on survival for gastric cancer after distal subtotal gastrectomy. Gastroenterol Res Pract 2011;2011:476014. [PMID: 21811495 DOI: 10.1155/2011/476014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
56 Douridas GN, Pierrakakis SK. Is There Any Role for D3 Lymphadenectomy in Gastric Cancer? Front Surg. 2018;5:27. [PMID: 29740588 DOI: 10.3389/fsurg.2018.00027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Yang K, Hu JK. Gastric cancer treatment: similarity and difference between China and Korea. Transl Gastroenterol Hepatol 2017;2:36. [PMID: 28529990 DOI: 10.21037/tgh.2017.04.02] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
58 Yuan SQ, Chen YT, Huang ZP. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis. J Gastrointest Surg 2017;21:1591-8. [PMID: 28752402 DOI: 10.1007/s11605-017-3504-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
59 Qiu M, Peng XC, Bi F, Wang X, Li Q, Xu F, Li ZP, Shen YL, Liu JY, Zhao YQ, Cao D, Gou HF, Yang Y, Chen Y, Yi C. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer. Med Oncol 2015;32:191. [PMID: 26025485 DOI: 10.1007/s12032-015-0635-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Oh SC, Sur HY, Sung HJ, Choi IK, Park SS, Seo JH, Jeen YT, Chun HJ, Shin SW, Mok YJ, Kim JS, Kim YH. A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. Br J Cancer 2007;96:1514-9. [PMID: 17473829 DOI: 10.1038/sj.bjc.6603752] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
61 Jagric T, Horvat M. Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study. Radiol Oncol 2020;55:57-65. [PMID: 33885239 DOI: 10.2478/raon-2020-0067] [Reference Citation Analysis]
62 Narayan RR, Poultsides GA. Advances in the surgical management of gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2021;6:16. [PMID: 33409410 DOI: 10.21037/tgh.2020.02.06] [Reference Citation Analysis]
63 Huang ZN, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH. Learning Curve of the Application of Huang Three-Step Maneuver in a Laparoscopic Spleen-Preserving Splenic Hilar Lymphadenectomy for Advanced Gastric Cancer. Medicine (Baltimore). 2016;95:e3252. [PMID: 27043698 DOI: 10.1097/md.0000000000003252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
64 Schernberg A, Rivin Del Campo E, Rousseau B, Matzinger O, Loi M, Maingon P, Huguet F. Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives. Clin Transl Radiat Oncol 2018;10:13-22. [PMID: 29928701 DOI: 10.1016/j.ctro.2018.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
65 Anderson C, Ellenhorn J, Hellan M, Pigazzi A. Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer. Surg Endosc. 2007;21:1662-1666. [PMID: 17345142 DOI: 10.1007/s00464-007-9266-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
66 Zhang WH, Chen XZ, Liu K, Chen XL, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital. Med Oncol. 2014;31:150. [PMID: 25112468 DOI: 10.1007/s12032-014-0150-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
67 Uyama I, Suda K, Satoh S. Laparoscopic surgery for advanced gastric cancer: current status and future perspectives. J Gastric Cancer. 2013;13:19-25. [PMID: 23610715 DOI: 10.5230/jgc.2013.13.1.19] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
68 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer. World J Gastroenterol 2014;20:3889-904. [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
69 Tegels JJ, Silvius CE, Spauwen FE, Hulsewé KW, Hoofwijk AG, Stoot JH. Introduction of laparoscopic gastrectomy for gastric cancer in a Western tertiary referral centre: A prospective cost analysis during the learning curve. World J Gastrointest Oncol 2017;9:228-34. [PMID: 28567187 DOI: 10.4251/wjgo.v9.i5.228] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wong RK, Jang R, Darling G. Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. J Gastrointest Oncol. 2015;6:89-107. [PMID: 25642342 DOI: 10.3978/j.issn.2078-6891.2014.089] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
71 Chen X, Eads JR, Ammori JB, Kumar AM, Biswas T, Dorth JA. Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach? Curr Oncol Rep 2015;17:18. [PMID: 25708803 DOI: 10.1007/s11912-015-0442-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Tegels JJ, de Maat MF, Hulsewé KW, Hoofwijk AG, Stoot JH. Value of geriatric frailty and nutritional status assessment in predicting postoperative mortality in gastric cancer surgery. J Gastrointest Surg. 2014;18:439-445; discussion 445-446. [PMID: 24420730 DOI: 10.1007/s11605-013-2443-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 9.6] [Reference Citation Analysis]
73 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
74 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
75 Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y, Fukunaga T, Gotoh M, Emi Y, Yoshida K, Oki E, Takahashi S, Kuriki H, Sato K, Sasako M. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer. 2017;20:332-340. [PMID: 26956689 DOI: 10.1007/s10120-016-0606-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
76 Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg 2016;8:294-300. [PMID: 27152135 DOI: 10.4240/wjgs.v8.i4.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
77 Jansen EP, Boot H, Dubbelman R, Bartelink H, Cats A, Verheij M. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer 2007;97:712-6. [PMID: 17848909 DOI: 10.1038/sj.bjc.6603965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
78 Rausei S, Dionigi G, Rovera F, Boni L, Valerii C, Giavarini L, Frattini F, Dionigi R. A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J Gastrointest Surg 2012;4:45-54. [PMID: 22530078 DOI: 10.4240/wjgs.v4.i3.45] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
79 Bickenbach K, Strong VE. Comparisons of Gastric Cancer Treatments: East vs. West. J Gastric Cancer. 2012;12:55-62. [PMID: 22792517 DOI: 10.5230/jgc.2012.12.2.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 8.9] [Reference Citation Analysis]
80 Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit. Oncologist 2017;22:97-106. [PMID: 27789777 DOI: 10.1634/theoncologist.2016-0239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
81 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D'Ugo D. R0 resection in the treatment of gastric cancer: room for improvement. World J Gastroenterol 2010;16:3358-70. [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
82 Tokunaga M, Hiki N, Fukunaga T, Nohara K, Katayama H, Akashi Y, Ohyama S, Yamaguchi T. Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection Following Standardization—A Preliminary Study. J Gastrointest Surg 2009;13:1058-63. [DOI: 10.1007/s11605-009-0840-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
83 Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Ferrari GC, Di Lernia S, Costanzi A, Pauna J, de Martini P. Total and subtotal laparoscopic gastrectomy for adenocarcinoma. Surg Endosc. 2007;21:21-27. [PMID: 17031743 DOI: 10.1007/s00464-005-0409-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
84 Ahn HS, Sohn TS, Kim MJ, Cho BK, Kim SM, Kim ST, Yi EC, Lee C. SEPROGADIC - serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy. Sci Rep 2018;8:16892. [PMID: 30442939 DOI: 10.1038/s41598-018-34858-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
85 Mirkin KA, Hollenbeak CS, Wong J. Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United States. J Gastric Cancer 2017;17:306-18. [PMID: 29302371 DOI: 10.5230/jgc.2017.17.e35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
86 Griniatsos J, Gakiopoulou H, Yiannakopoulou E, Dimitriou N, Douridas G, Nonni A, Liakakos T, Felekouras E. Routine modified D2 lymphadenectomy performance in pT1-T2N0 gastric cancer. World J Gastroenterol. 2009;15:5568-5572. [PMID: 19938196 DOI: 10.3748/wjg.15.5568] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
87 Luna A, Rebasa P, Montmany S, Navarro S. Learning curve for d2 Lymphadenectomy in gastric cancer. ISRN Surg. 2013;2013:508719. [PMID: 23844296 DOI: 10.1155/2013/508719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
88 Hwang SH, Kim HI, Song JS, Lee MH, Kwon SJ, Kim MG. The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System. J Gastric Cancer 2016;16:207-14. [PMID: 28053806 DOI: 10.5230/jgc.2016.16.4.207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One. 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424.] [Reference Citation Analysis]
90 Merrett ND. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects. World J Gastroenterol. 2014;20:12892-12899. [PMID: 25278686 DOI: 10.3748/wjg.v20.i36.12892] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
91 Antonakis PT, Ashrafian H, Isla AM. Laparoscopic gastric surgery for cancer: where do we stand? World J Gastroenterol 2014;20:14280-91. [PMID: 25339815 DOI: 10.3748/wjg.v20.i39.14280] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
92 Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg. 2005;29:1576-1584. [PMID: 16317484 DOI: 10.1007/s00268-005-7907-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
93 Buergy D, Lohr F, Baack T, Siebenlist K, Haneder S, Michaely H, Wenz F, Boda-Heggemann J. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. Radiat Oncol. 2012;7:192. [PMID: 23157945 DOI: 10.1186/1748-717x-7-192] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
94 Hackenson D, Edelman DA, McGuire T, Weaver DW, Webber JD. Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family. JSLS 2010;14:348-52. [PMID: 21333186 DOI: 10.4293/108680810X12924466007449] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
95 Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30:2327-33. [PMID: 22585691 DOI: 10.1200/JCO.2011.36.7136] [Cited by in Crossref: 466] [Cited by in F6Publishing: 217] [Article Influence: 51.8] [Reference Citation Analysis]
96 Brenkman HJF, Visser E, van Rossum PSN, Siesling S, van Hillegersberg R, Ruurda JP. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands. Ann Surg Oncol 2017;24:1761-9. [PMID: 28353020 DOI: 10.1245/s10434-017-5820-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
97 Cui M, Xing JD, Yang W, Ma YY, Yao ZD, Zhang N, Su XQ. D2 dissection in laparoscopic and open gastrectomy for gastric cancer. World J Gastroenterol 2012;18:833-9. [PMID: 22371644 DOI: 10.3748/wjg.v18.i8.833] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
98 Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol 2012;3:209-25. [PMID: 22943012 DOI: 10.3978/j.issn.2078-6891.2012.024] [Reference Citation Analysis]
99 Park JM, Kim JH, Park SS, Kim SJ, Mok YJ, Kim CS. Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II. World J Surg. 2008;32:1037-1044. [PMID: 18347851 DOI: 10.1007/s00268-007-9440-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
100 Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol. 2010;16:5621-5628. [PMID: 21105197 DOI: 10.3748/wjg.v17.i40.4542] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
101 Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA, Wijnhoven BP, van Lanschot JJ, de Steur WO. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556. [PMID: 26219670 DOI: 10.1186/s12885-015-1551-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
102 Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, Kook MC, Choi IJ, Kim YW, Park JG. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588-2592. [PMID: 16688807 DOI: 10.3748/wjg.v12.i16.2588] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
103 Ishikawa S, Shimada S, Miyanari N, Hirota M, Takamori H, Baba H. Pattern of lymph node involvement in proximal gastric cancer. World J Surg. 2009;33:1687-1692. [PMID: 19488813 DOI: 10.1007/s00268-009-0083-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
104 Zulfikaroglu B, Kucuk O, Soydal C, Mahir Ozmen M. Lymph Node Mapping in Gastric Cancer Surgery: Current Status and New Horizons. Turk J Surg 2020;36:393-8. [PMID: 33778399 DOI: 10.47717/turkjsurg.2020.4932] [Reference Citation Analysis]
105 Sah BK, Chen MM, Yan M, Zhu ZG. Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital. World J Gastroenterol 2010;16:98-103. [PMID: 20039455 DOI: 10.3748/wjg.v16.i1.98] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
106 Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg. 2007;11:158-165. [PMID: 17390167 DOI: 10.1007/s11605-006-0018-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
107 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
108 Galizia G, Lieto E, Orditura M, Castellano P, Mura AL, Imperatore V, Pinto M, Zamboli A, De Vita F, Ferraraccio F. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458-1468. [PMID: 17516110 DOI: 10.1007/s00268-007-9016-4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 8.0] [Reference Citation Analysis]
109 Nobuoka D, Gotohda N, Kato Y, Takahashi S, Konishi M, Kinoshita T. Influence of excess body weight on the surgical outcomes of total gastrectomy. Surg Today 2011;41:928-34. [DOI: 10.1007/s00595-010-4397-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
110 Ringash J, Smalley SR, Gunderson LL. Locoregional control remains a critical issue in gastric cancer. Gastric Cancer 2008;11:64-5. [PMID: 18373180 DOI: 10.1007/s10120-008-0454-y] [Reference Citation Analysis]
111 Liu X, Xue Z, Yu J, Li Z, Ma Z, Kang W, Ye X, Jiang L. Risk Factors for Postoperative Infectious Complications in Elderly Patients with Gastric Cancer. Cancer Manag Res 2020;12:4391-8. [PMID: 32606934 DOI: 10.2147/CMAR.S253649] [Reference Citation Analysis]
112 Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study. Fam Cancer 2014;13:231-42. [PMID: 24389957 DOI: 10.1007/s10689-013-9698-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
113 Meyer HJ, Hölscher AH, Lordick F, Messmann H, Mönig S, Schumacher C, Stahl M, Wilke H, Möhler M. [Current S3 guidelines on surgical treatment of gastric carcinoma]. Chirurg 2012;83:31-7. [PMID: 22127381 DOI: 10.1007/s00104-011-2149-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
114 Kurokawa Y, Yamaguchi T, Sasako M, Sano T, Mizusawa J, Nakamura K, Fukuda H. Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502). Gastric Cancer 2017;20:508-16. [PMID: 27568321 DOI: 10.1007/s10120-016-0636-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
115 Khachfe HH, Salhab HA, Fares MY, Chahrour MA, Jamali FR. Landscape of interventional clinical trials involving gastrectomy for gastric cancer. Ecancermedicalscience 2021;15:1218. [PMID: 34158822 DOI: 10.3332/ecancer.2021.1218] [Reference Citation Analysis]
116 Rajdev L. Treatment options for surgically resectable gastric cancer. Curr Treat Options Oncol. 2010;11:14-23. [PMID: 20358316 DOI: 10.1007/s11864-010-0117-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
117 Mickevicius A, Ignatavicius P, Markelis R, Parseliunas A, Butkute D, Kiudelis M, Endzinas Z, Maleckas A, Dambrauskas Z. Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study. BMC Surg 2014;14:98. [PMID: 25428767 DOI: 10.1186/1471-2482-14-98] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
118 Ichikura T, Chochi K, Sugasawa H, Mochizuki H. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer. Langenbecks Arch Surg 2005;390:397-402. [PMID: 16041552 DOI: 10.1007/s00423-005-0570-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
119 Hu JK, Yang K, Zhang B, Chen XZ, Chen ZX, Chen JP. D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today. 2009;39:207-213. [PMID: 19280279 DOI: 10.1007/s00595-008-3856-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
120 Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc. 2010;24:304-334. [PMID: 19572178 DOI: 10.1007/s00464-009-0583-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
121 Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017;35:3671-3677. [PMID: 28976791 DOI: 10.1200/jco.2017.74.2130] [Cited by in Crossref: 62] [Cited by in F6Publishing: 14] [Article Influence: 15.5] [Reference Citation Analysis]
122 Dikken JL, van Sandick JW, Maurits Swellengrebel HA, Lind PA, Putter H, Jansen EP, Boot H, van Grieken NC, van de Velde CJ, Verheij M. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer. 2011;11:329. [PMID: 21810227 DOI: 10.1186/1471-2047.11-329] [Reference Citation Analysis]
123 Hsu JT, Liu MS, Wang F, Chang CJ, Hwang TL, Jan YY, Yeh TS. Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are short-term surgical results and long-term survival substantial? J Gastrointest Surg. 2012;16:728-737. [PMID: 22350724 DOI: 10.1007/s11605-012-1835-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
124 Stewart P, Boonsiri P, Puthong S, Rojpibulstit P. Antioxidant activity and ultrastructural changes in gastric cancer cell lines induced by Northeastern Thai edible folk plant extracts. BMC Complement Altern Med 2013;13:60. [PMID: 23497063 DOI: 10.1186/1472-6882-13-60] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
125 Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Whang-Peng J. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008;98:54-9. [PMID: 18182977 DOI: 10.1038/sj.bjc.6604097] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
126 Gurusamy KS, Imber C, Davidson BR. Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg 2008;2008:684150. [PMID: 18475315 DOI: 10.1155/2008/684150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
127 Farhat S, Coriat R, Audard V, Leblanc S, Prat F, Chaussade S. Is Endoscopic Submucosal Dissection the Option for Early Gastric Cancer Patients with Contraindication to Surgery? Case Rep Gastroenterol. 2010;4:307-312. [PMID: 21060691 DOI: 10.1159/000320629] [Reference Citation Analysis]
128 Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 2017;10:149. [PMID: 28810883 DOI: 10.1186/s13045-017-0517-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
129 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located in the Lower Third of the Stomach. Yonago Acta Med. 2018;61:175-181. [PMID: 30275748 DOI: 10.33160/yam.2018.09.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Degiuli M, De Manzoni G, Di Leo A, D'Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol. 2016;22:2875-2893. [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 35] [Article Influence: 13.3] [Reference Citation Analysis]
131 Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005;9:718-725. [PMID: 15862270 DOI: 10.1016/j.gassur.2004.12.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 5.8] [Reference Citation Analysis]
132 Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, Kim J. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;17:471-481. [PMID: 23288716 DOI: 10.1007/s11605-012-2125-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
133 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
134 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer. World J Surg. 2013;37:1072-1081. [PMID: 23408049 DOI: 10.1007/s00268-013-1942-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
135 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
136 Díaz de Liaño A, Yárnoz C, Artieda C, Aguilar R, Viana S, Artajona A, Ortiz H. Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer. Clin Transl Oncol 2009;11:178-82. [PMID: 19293056 DOI: 10.1007/s12094-009-0335-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
137 Hartgrink HH. Improving outcome for scirrhous gastric cancer. Gastric Cancer 2009;12:3-5. [PMID: 19390926 DOI: 10.1007/s10120-009-0501-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Kim HI, Hur H, Kim YN, Lee HJ, Kim MC, Han SU, Hyung WJ. Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893]. BMC Cancer. 2014;14:209. [PMID: 24646327 DOI: 10.1186/1471-2407-14-209] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
139 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21:11428-11438. [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 73] [Article Influence: 19.2] [Reference Citation Analysis]
140 Eom BW, Joo J, Kim YW, Park B, Yoon HM, Ryu KW, Kim SJ. Nomogram Estimating the Probability of Intraabdominal Abscesses after Gastrectomy in Patients with Gastric Cancer. J Gastric Cancer 2015;15:262-9. [PMID: 26816657 DOI: 10.5230/jgc.2015.15.4.262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Zhang H, Liu C, Wu D, Meng Y, Song R, Lu P, Wang S. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer. 2010;10:308. [PMID: 20565910 DOI: 10.1186/1471-2407-10-308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
142 Kusano T, Shiraishi N, Shiroshita H, Etoh T, Inomata M, Kitano S. Poor prognosis of advanced gastric cancer with metastatic suprapancreatic lymph nodes. Ann Surg Oncol. 2013;20:2290-2295. [PMID: 23299769 DOI: 10.1245/s10434-012-2839-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
143 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
144 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 369] [Article Influence: 52.9] [Reference Citation Analysis]
145 Chen YC, Fang WL, Wang RF, Liu CA, Yang MH, Lo SS, Wu CW, Li AF, Shyr YM, Huang KH. Clinicopathological Variation of Lauren Classification in Gastric Cancer. Pathol Oncol Res. 2016;22:197-202. [PMID: 26502923 DOI: 10.1007/s12253-015-9996-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]
146 Gallo A, Cha C. Updates on esophageal and gastric cancers. World J Gastroenterol 2006;12:3237-42. [PMID: 16718845 DOI: 10.3748/wjg.v12.i20.3237] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
147 Pareekutty NM, Kadam S, Ankalkoti B, Balasubramanian S, Anilkumar B. Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India. Indian J Surg Oncol 2020;11:256-62. [PMID: 32523272 DOI: 10.1007/s13193-020-01059-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Friedel D, Zhang X, Stavropoulos SN. Burgeoning study of sentinel-node analysis on management of early gastric cancer after endoscopic submucosal dissection. World J Gastrointest Endosc 2020;12:119-27. [PMID: 32341748 DOI: 10.4253/wjge.v12.i4.119] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
149 Jain VK, Cunningham D, Rao S. Chemotherapy for operable gastric cancer: current perspectives. Indian J Surg Oncol. 2011;2:334-342. [PMID: 23204792 DOI: 10.1007/s13193-012-0139-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
150 Zhao LY, Zhang WH, Sun Y, Chen XZ, Yang K, Liu K, Chen XL, Wang YG, Song XH, Xue L, Zhou ZG, Hu JK. Learning curve for gastric cancer patients with laparoscopy-assisted distal gastrectomy: 6-year experience from a single institution in western China. Medicine (Baltimore) 2016;95:e4875. [PMID: 27631257 DOI: 10.1097/MD.0000000000004875] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
151 de Burlet KJ, van den Hout MF, Putter H, Smit VT, Hartgrink HH. Total number of lymph nodes in oncologic resections, is there more to be found? J Gastrointest Surg. 2015;19:943-948. [PMID: 25691110 DOI: 10.1007/s11605-015-2764-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
152 Ashraf N, Hoffe S, Kim R. Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist 2013;18:1013-21. [PMID: 23966224 DOI: 10.1634/theoncologist.2012-0462] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
153 Heemskerk VH, Lentze F, Hulsewé KW, Hoofwijk TG. Gastric carcinoma: review of the results of treatment in a community teaching hospital. World J Surg Oncol 2007;5:81. [PMID: 17659085 DOI: 10.1186/1477-7819-5-81] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
154 Ott K, Lordick F, Blank S, Büchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011;396:743-58. [PMID: 21234760 DOI: 10.1007/s00423-010-0738-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
155 Arai H, Nakajima TE. Recent Developments of Systemic Chemotherapy for Gastric Cancer. Cancers (Basel) 2020;12:E1100. [PMID: 32354119 DOI: 10.3390/cancers12051100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
156 Wong J. Effect of laparoscopic vs. open distal gastrectomy on 3-year disease free survival in patients with locally advanced gastric cancer: commentary on the class-01 randomized clinical trial. Transl Gastroenterol Hepatol 2019;4:78. [PMID: 31872142 DOI: 10.21037/tgh.2019.09.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
157 Wang W, Li Z, Tang J, Wang M, Wang B, Xu Z. Laparoscopic versus open total gastrectomy with D2 dissection for gastric cancer: a meta-analysis. J Cancer Res Clin Oncol. 2013;139:1721-1734. [PMID: 23990014 DOI: 10.1007/s00432-013-1462-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
158 Herbella FA, Tineli AC, Wilson JL, Del Grande JC. Gastrectomy and Lymphadenectomy for Gastric Cancer: is the Pancreas Safe? J Gastrointest Surg 2008;12:1912-4. [DOI: 10.1007/s11605-008-0572-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
159 Meyer L, Meyer F, Dralle H, Ernst M, Lippert H, Gastinger I; East German Study Group for Quality Control in Operative Medicine and Regional Development in Surgery. Insufficiency risk of esophagojejunal anastomosis after total abdominal gastrectomy for gastric carcinoma. Langenbecks Arch Surg. 2005;390:510-516. [PMID: 16086189 DOI: 10.1007/s00423-005-0575-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
160 Sah BK, Zhu ZG, Wang XY, Yang QM, Chen MM, Xiang M, Chen J, Yan M. Post-operative complications of gastric cancer surgery: female gender at high risk. Eur J Cancer Care (Engl) 2009;18:202-8. [PMID: 19267738 DOI: 10.1111/j.1365-2354.2008.01036.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
161 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol. 2014;20:13667-13680. [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
162 Chen YH, Lu J, Nie RC, Liu D, Liu AH, Deng ZJ, Chen XJ, Xiang J, Chen YB, Huang CM, Chen S, Peng JS. Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients. Front Oncol 2021;11:593470. [PMID: 33996537 DOI: 10.3389/fonc.2021.593470] [Reference Citation Analysis]
163 Ridwelski K, Gastinger I, Ptok H, Meyer F, Dralle H, Lippert H. [Surgical treatment of gastric carcinoma. German multicenter observational studies]. Chirurg. 2013;84:46-52. [PMID: 23329311 DOI: 10.1007/s00104-012-2394-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
164 Tamura S, Takeno A, Miki H. Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol. 2011;2011:748745. [PMID: 22312521 DOI: 10.1155/2011/748745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
165 Agolli L, Maurizi Enrici R, Osti MF. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? World J Gastroenterol 2016;22:1131-8. [PMID: 26811652 DOI: 10.3748/wjg.v22.i3.1131] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
166 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010.surgical] [Reference Citation Analysis]
167 Alkhaffaf B, Blazeby JM, Williamson PR, Bruce IA, Glenny AM. Reporting of outcomes in gastric cancer surgery trials: a systematic review. BMJ Open 2018;8:e021796. [PMID: 30337308 DOI: 10.1136/bmjopen-2018-021796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
168 Merchant SJ, Li L, Kim J. Racial and ethnic disparities in gastric cancer outcomes: more important than surgical technique? World J Gastroenterol. 2014;20:11546-11551. [PMID: 25206261 DOI: 10.3748/wjg.v20.i33.11546] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
169 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, De Manzoni G. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol. 2014;20:12883-12891. [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
170 Zhu X, Li J. Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett 2010;1:407-12. [PMID: 22966316 DOI: 10.3892/ol_00000071] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
171 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
172 Girardi DM, de Lima MA, Pereira GCB, Negrão MV, López RVM, Capareli FC, Sabbaga J, Hoff PMG. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. BMC Cancer 2018;18:378. [PMID: 29614980 DOI: 10.1186/s12885-018-4305-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Wang P, Zhou H, Han G, Ni Q, Dai S, Huang J, Dai C, Yu L. Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression. World J Surg Oncol 2021;19:205. [PMID: 34238296 DOI: 10.1186/s12957-021-02304-4] [Reference Citation Analysis]
174 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Reference Citation Analysis]
175 Ke B, Liang H. Current status of lymph node dissection in gastric cancer. Chin J Cancer Res 2021;33:193-202. [PMID: 34158739 DOI: 10.21147/j.issn.1000-9604.2021.02.07] [Reference Citation Analysis]
176 Moisan F, Norero E, Slako M, Varas J, Palominos G, Crovari F, Ibañez L, Pérez G, Pimentel F, Guzmán S, Jarufe N, Boza C, Escalona A, Funke R. Completely laparoscopic versus open gastrectomy for early and advanced gastric cancer: a matched cohort study. Surg Endosc 2012;26:661-72. [PMID: 22011940 DOI: 10.1007/s00464-011-1933-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
177 Satolli MA, Buffoni L, Spadi R, Roato I. Gastric cancer: The times they are a-changin'. World J Gastrointest Oncol 2015;7:303-16. [PMID: 26600930 DOI: 10.4251/wjgo.v7.i11.303] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
178 Chang JS, Koom WS, Lee Y, Yoon HI, Lee HS. Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection? World J Gastroenterol. 2014;20:12900-12907. [PMID: 25278687 DOI: 10.3748/wjg.v20.i36.12900] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
179 Martinson HA, Shelby NJ, Alberts SR, Olnes MJ. Gastric cancer in Alaska Native people: A cancer health disparity. World J Gastroenterol 2018;24:2722-32. [PMID: 29991877 DOI: 10.3748/wjg.v24.i25.2722] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
180 Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019;39:11. [PMID: 30917873 DOI: 10.1186/s40880-019-0360-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
181 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17:2059-2066. [PMID: 24129828 DOI: 10.1007/s11605-013-2380-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
182 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
183 Tsirlis TD, Papastratis G, Masselou K, Tsigris C, Papachristodoulou A, Kostakis A, Nikiteas NI. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008;14:2691-701. [PMID: 18461654 DOI: 10.3748/wjg.14.2691] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
184 Gholami S, Janson L, Worhunsky DJ, Tran TB, Squires MH 3rd, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber SM, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Efron B, Norton JA, Poultsides GA. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221:291-299. [PMID: 26206635 DOI: 10.1016/j.jamcollsurg.2015.04.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
185 Gupta V, Raju K, Rao TS, Naidu CK, Goel V, Hariharan N, Nagarajuch R, Madhunarayana B. A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. Indian J Surg Oncol 2020;11:216-22. [PMID: 32523266 DOI: 10.1007/s13193-019-01023-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
187 Lynch HT, Silva E, Wirtzfeld D, Hebbard P, Lynch J, Huntsman DG. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin North Am 2008;88:759-78, vi-vii. [PMID: 18672140 DOI: 10.1016/j.suc.2008.04.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
188 Cao S, Zhou Y, Chen D, Niu Z, Wang D, Lv L, Li Y. Intensive versus conventional insulin therapy in nondiabetic patients receiving parenteral nutrition after D2 gastrectomy for gastric cancer: a randomized controlled trial. J Gastrointest Surg 2011;15:1961-8. [PMID: 21904964 DOI: 10.1007/s11605-011-1654-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
189 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 2014;18:505-11. [PMID: 24443204 DOI: 10.1007/s11605-014-2455-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
190 Chandran S, Vaughan R, Efthymiou M, Sia J, Hamilton C. A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer. Endosc Int Open 2014;2:E153-9. [PMID: 26134962 DOI: 10.1055/s-0034-1377523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
191 Yu JH, Wang ZZ, Fan YC, Liu MX, Xu K, Zhang N, Yao ZD, Yang H, Zhang CH, Xing JD, Cui M, Su XQ. Comparison of neoadjuvant chemotherapy followed by surgery vs. surgery alone for locally advanced gastric cancer: a meta-analysis. Chin Med J (Engl) 2021;134:1669-80. [PMID: 34397593 DOI: 10.1097/CM9.0000000000001603] [Reference Citation Analysis]
192 Li P, Huang CM, Zheng CH, Xie JW, Wang JB, Lin JX, Lu J, Wang Y, Chen QY. Laparoscopic spleen-preserving splenic hilar lymphadenectomy in 108 consecutive patients with upper gastric cancer. World J Gastroenterol. 2014;20:11376-11383. [PMID: 25170225 DOI: 10.3748/wjg.v20.i32.11376] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
193 Gretschel S, Estevez-Schwarz L, Hünerbein M, Schneider U, Schlag PM. Gastric cancer surgery in elderly patients. World J Surg. 2006;30:1468-1474. [PMID: 16850149 DOI: 10.1007/s00268-005-0633-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
194 Lorenzon L, Giudicissi R, Scatizzi M, Balducci G, Cantafio S, Biondi A, Persiani R, Mercantini P, D'Ugo D. D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literature. BMC Surg 2020;20:126. [PMID: 32522177 DOI: 10.1186/s12893-020-00714-x] [Reference Citation Analysis]
195 Sasako M. Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol. 2005;10:165-170. [PMID: 15990963 DOI: 10.1007/s10147-005-0486-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
196 Bollschweiler E, Lubke T, Monig SP, Holscher AH. Evaluation of POSSUM scoring system in patients with gastric cancer undergoing D2-gastrectomy. BMC Surg 2005;5:8. [PMID: 15831104 DOI: 10.1186/1471-2482-5-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
197 Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 2010;16:868-74. [PMID: 20143466 DOI: 10.3748/wjg.v16.i7.868] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
198 Shum H, Rajdev L. Multimodality management of resectable gastric cancer: A review. World J Gastrointest Oncol. 2014;6:393-402. [PMID: 25320655 DOI: 10.4251/wjgo.v6.i10.393] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
199 Lim DH, Kim HS, Park YS, Lee J, Park SH, Lim HY, Ji SH, Park MJ, Yi SY, An JY, Sohn TS, Noh JH, Bae JM, Kim S, Park CK, Kang WK. Metastatic lymph node in gastric cancer; is it a real distant metastasis? BMC Cancer 2010;10:25. [PMID: 20113485 DOI: 10.1186/1471-2407-10-25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
200 Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. J Gastric Cancer 2018;18:348-55. [PMID: 30607298 DOI: 10.5230/jgc.2018.18.e34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
201 Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci. 2007;52:543-548. [PMID: 17211711 DOI: 10.1007/s10620-006-9317-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
202 Li C, Su D, Xie C, Chen Q, Zhou J, Wu X. Lymphadenectomy is associated with poor survival in patients with gastrointestinal stromal tumors. Ann Transl Med 2019;7:558. [PMID: 31807539 DOI: 10.21037/atm.2019.09.60] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
203 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
204 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, Scardino PT, Vickers A. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol 2021;4:532-9. [PMID: 33865797 DOI: 10.1016/j.euo.2021.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
206 Batista TP, Martins MR. Lymph node dissection for gastric cancer: a critical review. Oncol Rev 2012;6:e12. [PMID: 25992202 DOI: 10.4081/oncol.2012.e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
207 Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol. 2016;22:4041-4048. [PMID: 27099448 DOI: 10.3748/wjg.v22.i15.4041] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
208 Huang L, Zhang X, Wei Z, Xu A. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016. Front Oncol 2020;10:539030. [PMID: 33585181 DOI: 10.3389/fonc.2020.539030] [Reference Citation Analysis]
209 Dudeja V, Habermann EB, Abraham A, Zhong W, Parsons HM, Tseng JF, Al-Refaie WB. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma? J Gastrointest Surg. 2012;16:238-246; discussion 246-247. [PMID: 22089951 DOI: 10.1007/s11605-011-1756-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
210 Sianesi M, Bezer L, Del Rio P, Dell’Abate P, Iapichino G, Soliani P, Tacci S. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619. [PMID: 20101526 DOI: 10.1007/s11605-009-1142-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
211 Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF. Palliative resection in noncurative gastric cancer patients. World J Surg 2010;34:1015-21. [PMID: 20145923 DOI: 10.1007/s00268-010-0467-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
212 Lavy R, Kapiev A, Poluksht N, Halevy A, Keinan-Boker L. Incidence trends and mortality rates of gastric cancer in Israel. Gastric Cancer 2013;16:121-5. [PMID: 22527183 DOI: 10.1007/s10120-012-0155-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
213 Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Evolution of gastric surgery techniques and outcomes. Chin J Cancer 2016;35:69. [PMID: 27460019 DOI: 10.1186/s40880-016-0134-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
214 Brenkman HJF, Tegels JJW, Ruurda JP, Luyer MDP, Kouwenhoven EA, Draaisma WA, van der Peet DL, Wijnhoven BPL, Stoot JHMB, van Hillegersberg R;  LOGICA Study Group. Factors influencing health-related quality of life after gastrectomy for cancer. Gastric Cancer. 2018;21:524-532. [PMID: 29067597 DOI: 10.1007/s10120-017-0771-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
215 Obertop H. How surgeons make decisions: authority and evidence. Ann Surg 2005;242:753-6. [PMID: 16327484 DOI: 10.1097/01.sla.0000189110.37637.6b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
216 Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, Boehlke I, Kollmannsberger C; German AIO/ARO/CAO group. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. J Cancer Res Clin Oncol 2009;135:163-72. [PMID: 18825411 DOI: 10.1007/s00432-008-0463-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
217 Ao S, Wang Y, Song Q, Ye Y, Lyu G. Current status and future perspectives on neoadjuvant therapy in gastric cancer. Chin J Cancer Res 2021;33:181-92. [PMID: 34158738 DOI: 10.21147/j.issn.1000-9604.2021.02.06] [Reference Citation Analysis]
218 Lee S, Son T, Kim HI, Hyung WJ. Status and Prospects of Robotic Gastrectomy for Gastric Cancer: Our Experience and a Review of the Literature. Gastroenterol Res Pract 2017;2017:7197652. [PMID: 28626474 DOI: 10.1155/2017/7197652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
219 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
220 Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013;5:48-63. [PMID: 24216698 DOI: 10.3390/cancers5010048] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 12.8] [Reference Citation Analysis]
221 Ott K, Lordick F, Herrmann K, Krause BJ, Schuhmacher C, Siewert JR. The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies. Gastric Cancer. 2008;11:1-9. [PMID: 18373171 DOI: 10.1007/s10120-007-0448-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
222 Nussbaum DP, Rushing CN, Sun Z, Yerokun BA, Worni M, Saunders RS, McClellan MB, Niedzwiecki D, Greenup RA, Blazer DG 3rd. Hospital-level compliance with the commission on cancer's quality of care measures and the association with patient survival. Cancer Med 2021;10:3533-44. [PMID: 33943026 DOI: 10.1002/cam4.3875] [Reference Citation Analysis]
223 Degiuli M, Calvo F. Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg. 2006;30:2193-2203. [PMID: 17103096 DOI: 10.1007/s00268-006-0179-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
224 Moehler M, Baltin CTH, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer H, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer 2015;18:550-63. [DOI: 10.1007/s10120-014-0403-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
225 Díaz de Liaño A, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer 2008;11:96-102. [PMID: 18595016 DOI: 10.1007/s10120-008-0460-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
226 Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol 2021;32:12-6. [DOI: 10.4103/0971-5851.81884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
227 Wong J, Kelly K, Mittra A, Gonzalez SJ, Song KY, Simpson G, Coffin R, Fong Y. A third-generation herpesvirus is effective against gastroesophageal cancer. J Surg Res 2010;163:214-20. [PMID: 20538290 DOI: 10.1016/j.jss.2010.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
228 Zhang M, Ding C, Xu L, Ou B, Feng S, Wang G, Wang W, Liang Y, Chen Y, Zhou Z, Qiu H. Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer. Front Oncol 2021;11:595421. [PMID: 34307116 DOI: 10.3389/fonc.2021.595421] [Reference Citation Analysis]
229 Macalindong SS, Kim KH, Nam BH, Ryu KW, Kubo N, Kim JY, Eom BW, Yoon HM, Kook MC, Choi IJ, Kim YW. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center. BMC Cancer. 2018;18:73. [PMID: 29329569 DOI: 10.1186/s12885-017-3872-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
230 Lin GT, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM. Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy. J Gastrointest Surg 2020;24:540-50. [PMID: 30937713 DOI: 10.1007/s11605-019-04199-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
231 Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA. High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection. Cell Oncol (Dordr) 2014;37:41-52. [PMID: 24379144 DOI: 10.1007/s13402-013-0162-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
232 Huang YY, Yang Q, Zhou SW, Wei Y, Chen YX, Xie DR, Zhang B. Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis. PLoS One. 2013;8:e68939. [PMID: 23874819 DOI: 10.1371/journal.pone.0068939] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
233 Tham CK, Choo SP, Poon DY, Toh HC, Ong SY, Tan SH, Wang ML, Foo KF. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. World J Gastroenterol 2010;16:3709-15. [PMID: 20677345 DOI: 10.3748/wjg.v16.i29.3709] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
234 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
235 Dikken JL, Verheij M, Cats A, Jansen EP, Hartgrink HH, van de Velde CJ. Extended lymph node dissection for gastric cancer from a European perspective. Gastric Cancer. 2011;14:396-398. [PMID: 21837457 DOI: 10.1007/s10120-011-0081-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]